These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

220 related items for PubMed ID: 29989856

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Chemotherapy and Risk of Subsequent Malignant Neoplasms in the Childhood Cancer Survivor Study Cohort.
    Turcotte LM, Liu Q, Yasui Y, Henderson TO, Gibson TM, Leisenring W, Arnold MA, Howell RM, Green DM, Armstrong GT, Robison LL, Neglia JP.
    J Clin Oncol; 2019 Dec 01; 37(34):3310-3319. PubMed ID: 31622130
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Long-Term Risk of Subsequent Malignant Neoplasms After Treatment of Childhood Cancer in the DCOG LATER Study Cohort: Role of Chemotherapy.
    Teepen JC, van Leeuwen FE, Tissing WJ, van Dulmen-den Broeder E, van den Heuvel-Eibrink MM, van der Pal HJ, Loonen JJ, Bresters D, Versluys B, Neggers SJCMM, Jaspers MWM, Hauptmann M, van der Heiden-van der Loo M, Visser O, Kremer LCM, Ronckers CM, DCOG LATER Study Group.
    J Clin Oncol; 2017 Jul 10; 35(20):2288-2298. PubMed ID: 28530852
    [Abstract] [Full Text] [Related]

  • 8. Clinical characteristics and survival patterns of subsequent sarcoma, breast cancer, and melanoma after childhood cancer in the DCOG-LATER cohort.
    Teepen JC, Kremer LC, van der Heiden-van der Loo M, Tissing WJ, van der Pal HJ, van den Heuvel-Eibrink MM, Loonen JJ, Louwerens M, Versluys B, van Dulmen-den Broeder E, Visser O, Maduro JH, van Leeuwen FE, Ronckers CM, DCOG-LATER Study Group.
    Cancer Causes Control; 2019 Sep 10; 30(9):909-922. PubMed ID: 31300947
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Second malignancies among survivors of germ-cell testicular cancer: a pooled analysis between 13 cancer registries.
    Richiardi L, Scélo G, Boffetta P, Hemminki K, Pukkala E, Olsen JH, Weiderpass E, Tracey E, Brewster DH, McBride ML, Kliewer EV, Tonita JM, Pompe-Kirn V, Kee-Seng C, Jonasson JG, Martos C, Brennan P.
    Int J Cancer; 2007 Feb 01; 120(3):623-31. PubMed ID: 17096341
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Increased risk of second malignant neoplasms in adolescents and young adults with cancer.
    Lee JS, DuBois SG, Coccia PF, Bleyer A, Olin RL, Goldsby RE.
    Cancer; 2016 Jan 01; 122(1):116-23. PubMed ID: 26441212
    [Abstract] [Full Text] [Related]

  • 15. Risk of subsequent malignant neoplasms in long-term hereditary retinoblastoma survivors after chemotherapy and radiotherapy.
    Wong JR, Morton LM, Tucker MA, Abramson DH, Seddon JM, Sampson JN, Kleinerman RA.
    J Clin Oncol; 2014 Oct 10; 32(29):3284-90. PubMed ID: 25185089
    [Abstract] [Full Text] [Related]

  • 16. Metachronous Contralateral Testicular Cancer in the Cisplatin Era: A Population-Based Cohort Study.
    Hellesnes R, Myklebust TÅ, Bremnes RM, Karlsdottir Á, Kvammen Ø, Negaard HFS, Tandstad T, Wilsgaard T, Fosså SD, Haugnes HS.
    J Clin Oncol; 2021 Feb 01; 39(4):308-318. PubMed ID: 33356420
    [Abstract] [Full Text] [Related]

  • 17. Second Malignant Neoplasms and Cause of Death in Patients With Germ Cell Cancer: A Danish Nationwide Cohort Study.
    Kier MG, Hansen MK, Lauritsen J, Mortensen MS, Bandak M, Agerbaek M, Holm NV, Dalton SO, Andersen KK, Johansen C, Daugaard G.
    JAMA Oncol; 2016 Dec 01; 2(12):1624-1627. PubMed ID: 27711914
    [Abstract] [Full Text] [Related]

  • 18. Treatment-specific risk of subsequent malignant neoplasms in five-year survivors of diffuse large B-cell lymphoma.
    Geurts YM, Neppelenbroek SIM, Aleman BMP, Janus CPM, Krol ADG, van Spronsen DJ, Plattel WJ, Roesink JM, Verschueren KMS, Zijlstra JM, Koene HR, Nijziel MR, Schimmel EC, de Jongh E, Ong F, Te Boome LCJ, van Rijn RS, Böhmer LH, Ta BDP, Visser HPJ, Posthuma EFM, Bilgin YM, Muller K, van Kampen D, So-Osman C, Vermaat JSP, de Weijer RJ, Kersten MJ, van Leeuwen FE, Schaapveld M.
    ESMO Open; 2024 Feb 01; 9(2):102248. PubMed ID: 38350338
    [Abstract] [Full Text] [Related]

  • 19. Cardiovascular Disease Mortality After Chemotherapy or Surgery for Testicular Nonseminoma: A Population-Based Study.
    Fung C, Fossa SD, Milano MT, Sahasrabudhe DM, Peterson DR, Travis LB.
    J Clin Oncol; 2015 Oct 01; 33(28):3105-15. PubMed ID: 26240226
    [Abstract] [Full Text] [Related]

  • 20. Long-term risk of second malignant neoplasms after neuroblastoma in childhood: role of treatment.
    Rubino C, Adjadj E, Guérin S, Guibout C, Shamsaldin A, Dondon MG, Valteau-Couanet D, Hartmann O, Hawkins M, de Vathaire F.
    Int J Cancer; 2003 Dec 10; 107(5):791-6. PubMed ID: 14566829
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.